Acorn Regulatory staff were among the members of a capacity audience at the HPRA seminar on MAH regulatory compliance inspection and advertising compliance programmes that was held at the Hilton Dublin on November 27th 2017.
The old adage ‘failing to plan is planning to fail’ could not be any truer when considering your regulatory strategy. A carefully crafted regulatory strategy is crucial when a pharmaceutical company wishes to market their medicinal product across regions subject to different regulatory requirements. One of the most critical elements in developing your regulatory strategy […]
Experts from Acorn Regulatory will be among the guest speakers at the Life Sciences Trends 2017 Conference in Little Island in Cork on November 15th next.
Acorn Regulatory has been exclusively retained by a global pharmaceutical company to identify and recruit a Head of Global Regulatory Affairs for their facility in Dublin, Ireland.
Regulatory professionals would generally perceive the Type I variation as a fairly simple regulatory procedure. New figures released by the EMA suggest differently. Statistical data released by the EMA has revealed that 44% of all Type I variation applications received for assessment by the EMA contain errors. It is reasonable to assume that these figures […]